Agios Pharmaceuticals AGIO Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$99.11M+8.3% | -$108.04M-4.5% | -$103.43M+7.7% | -$112.02M-25.5% | -$89.29M— | ||
| $1.36M+7.7% | $1.27M-7.9% | $1.37M+9.1% | $1.26M-1.5% | $1.28M-6.5% | ||
| $15.54M+10.0% | $14.12M+14.1% | $12.38M-15.8% | $14.69M+29.3% | $11.36M+4.2% | ||
| -$118.92M-23.6% | -$96.21M-9.1% | -$88.15M-14.3% | -$77.12M+30.8% | -$111.49M+16.3% | ||
| $769K-31.3% | $1.12M-28.0% | $1.56M+77.7% | $875K+14.2% | $766K-20.8% | ||
| $141.31M+56.9% | $90.08M-5.7% | $95.56M+21.0% | $78.97M-29.9% | $112.59M— | ||
| $2.08M-18.7% | $2.56M-42.3% | $4.44M+6,723% | $65K-96.0% | $1.62M-66.6% | ||
| $24.47M— | —— | $11.84M+521% | $1.91M-29.8% | $2.72M+102% | ||
| -$119.69M-23.0% | -$97.33M-8.5% | -$89.71M-15.0% | -$78M+30.5% | -$112.26M+16.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Agios Pharmaceuticals generate?
- Agios Pharmaceuticals (AGIO) generated -$380.4M in operating cash flow over the trailing twelve months.
- What is Agios Pharmaceuticals's free cash flow?
- After $4.3M of capital expenditures, Agios Pharmaceuticals's free cash flow was -$384.7M over the trailing twelve months, up 4.7% year over year.
- Where does Agios Pharmaceuticals's cash flow data come from?
- Every line is extracted from Agios Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
